Cardarine GW-501516 Liquid Solution (SARM)
Concentration of GW-501516: 25mg/ml
Packaging: Bottle 40ml
Exp. date: 04/2021
Serving size: 0.2ml
Amount per serving: 5mg
Servings per bottle: 200
Other ingredients: Distilled Water, Glycerin, Di-Sodium EDTA
Cardarine (GW50156) regulates fat burning through a number of mechanisms. It increases glucose uptake in skeletal muscle tissue and increases muscle gene expression, especially genes involved in preferential lipid utilization. This shift changes the body’s metabolism to favor burning fat for energy instead of carbohydrates or muscle protein, potentially allowing clinical application for obese patients to lose fat effectively without experiencing muscle catabolism or the effects and satiety issues associated with low blood sugar. Cardarine also increases muscle mass, which improved glucose tolerance and reduced fat mass accumulation even in mice fed a very high fat diet, suggesting that Cardarine may have a protective effect against obesity.
It has been demonstrated at an oral doses of just 5 mg a day to reverse metabolic abnormalities in obese mice with pre-diabetic metabolic syndrome, most likely by stimulating fatty acid oxidation. Treatments with GW-501516 have been also shown to increase HDL cholesterol by up to 79% in rhesus monkeys and the compound is now undergoing Phase II trials to improve HDL cholesterol.